--2025/Q1-- / 8.163M--
--2024/Q4-- / 7.273M--
Nov 13, 20242024/Q312.598M / 7.562M--
Aug 13, 20242024/Q22.293M / 8.721M--
May 9, 20242024/Q19.245M / 8.289M--
US Stock MarketDetailed Quotes
MRSN Mersana Therapeutics
- 2.575
- -0.055-2.09%
Trading Nov 14 13:22 ET
318.10MMarket Cap-4291P/E (TTM)
2.786High2.535Low328.96KVolume2.780Open2.630Pre Close868.19KTurnover0.45%Turnover RatioLossP/E (Static)123.53MShares6.28052wk High321.88P/B187.86MFloat Cap1.22052wk Low--Dividend TTM72.96MShs Float29.090Historical High--Div YieldTTM9.54%Amplitude0.801Historical Low2.639Avg Price1Lot Size
Mersana Therapeutics Key Stats
Mersana Therapeutics Q3 2024 Estimates Date
Currency：USDNov 13, 2024
| Estimate | YoY | |
| Revenue | 7.56M | -1.77% |
| EPS | -0.17 | +50.50% |
Analyst Rating
Nov 14, 2024
Mersana Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Mersana Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
